請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/104571完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 林菀俞 | zh_TW |
| dc.contributor.advisor | Wan-Yu Lin | en |
| dc.contributor.author | 楊正毅 | zh_TW |
| dc.contributor.author | Cheng-Yi Yang | en |
| dc.date.accessioned | 2026-08-28T16:26:24Z | - |
| dc.date.available | 2026-08-29 | - |
| dc.date.copyright | 2026-08-28 | - |
| dc.date.issued | 2026 | - |
| dc.date.submitted | 2026-08-17 00:14:33 | - |
| dc.identifier.citation | 1. Ding N, Sang Y, Chen J, Ballew SH, Kalbaugh CA, Salameh MJ, Blaha MJ, Allison M, Heiss G, Selvin E: Cigarette smoking, smoking cessation, and long-term risk of 3 major atherosclerotic diseases. Journal of the American College of Cardiology 2019, 74:498–507.
2. Ishida M, Sakai C, Kobayashi Y, Ishida T: Cigarette smoking and atherosclerotic cardiovascular disease. Journal of atherosclerosis and thrombosis 2024, 31:189–200. 3. Joseph P, Leong D, McKee M, Anand SS, Schwalm J-D, Teo K, Mente A, Yusuf S: Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circulation research 2017, 121:677–694. 4. Nakamura M, Yamamoto Y, Imaoka W, Kuroshima T, Toragai R, Ito Y, Kanda E, Schaefer EJ, Ai M: Relationships between smoking status, cardiovascular risk factors, and lipoproteins in a large Japanese population. Journal of atherosclerosis and thrombosis 2021, 28:942–953. 5. Opoku S, Gan Y, Fu W, Chen D, Addo-Yobo E, Trofimovitch D, Yue W, Yan F, Wang Z, Lu Z: Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP). BMC public health 2019, 19:1500. 6. Joehanes R, Just AC, Marioni RE, Pilling LC, Reynolds LM, Mandaviya PR, Guan W, Xu T, Elks CE, Aslibekyan S, et al: Epigenetic Signatures of Cigarette Smoking. Circ Cardiovasc Genet 2016, 9:436–447. 7. Gao X, Jia M, Zhang Y, Breitling LP, Brenner H: DNA methylation changes of whole blood cells in response to active smoking exposure in adults: a systematic review of DNA methylation studies. Clinical epigenetics 2015, 7:113. 8. Shenker NS, Polidoro S, van Veldhoven K, Sacerdote C, Ricceri F, Birrell MA, Belvisi MG, Brown R, Vineis P, Flanagan JM: Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. Hum Mol Genet 2013, 22:843–851. 9. Braun KVE, Dhana K, de Vries PS, Voortman T, van Meurs JBJ, Uitterlinden AG, Hofman A, Hu FB, Franco OH, Dehghan A, consortium B: Epigenome-wide association study (EWAS) on lipids: the Rotterdam Study. Clinical Epigenetics 2017, 9:15. 10. Sayols-Baixeras S, Subirana I, Lluis-Ganella C, Civeira F, Roquer J, Do AN, Absher D, Cenarro A, Muñoz D, Soriano-Tárraga C, et al: Identification and validation of seven new loci showing differential DNA methylation related to serum lipid profile: an epigenome-wide approach. The REGICOR study. Hum Mol Genet 2016, 25:4556–4565. 11. Wei CY, Yang JH, Yeh EC, Tsai MF, Kao HJ, Lo CZ, Chang LP, Lin WJ, Hsieh FJ, Belsare S, et al: Genetic profiles of 103,106 individuals in the Taiwan Biobank provide insights into the health and history of Han Chinese. NPJ Genom Med 2021, 6:10. 12. Lin W-Y: Epigenome-wide mediation analysis identified Cytosine-phosphate-Guanine sites linking environmental factors with diabetes indicators. Epigenomics 2026, 18:45–54. 13. Triche TJ, Jr., Weisenberger DJ, Van Den Berg D, Laird PW, Siegmund KD: Low-level processing of Illumina Infinium DNA Methylation BeadArrays. Nucleic Acids Res 2013, 41:e90. 14. Fortin J-P, Triche Jr TJ, Hansen KD: Preprocessing, normalization and integration of the Illumina HumanMethylationEPIC array with minfi. Bioinformatics 2017, 33:558–560. 15. Maksimovic J, Phipson B, Oshlack A: A cross-package Bioconductor workflow for analysing methylation array data. F1000Research 2016, 5:1281. 16. Fang H, Disteche CM, Berletch JB: X Inactivation and Escape: Epigenetic and Structural Features. Frontiers in Cell and Developmental Biology 2019, 7:219. 17. Du P, Zhang X, Huang C-C, Jafari N, Kibbe WA, Hou L, Lin SM: Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC bioinformatics 2010, 11:587. 18. Bland JM, Altman DG: Transformations, means, and confidence intervals. Bmj 1996, 312:1079. 19. Feng L, Nian S, Tong Z, Zhu Y, Li Y, Zhang C, Bai X, Luo X, Wu M, Yan Z: Age-related trends in lipid levels: a large-scale cross-sectional study of the general Chinese population. BMJ open 2020, 10:e034226. 20. Holven KB, van Lennep JR: Sex differences in lipids: a life course approach. Atherosclerosis 2023, 384:117270. 21. Lu S, Xie Q, Kuang M, Hu C, Li X, Yang H, Sheng G, Xie G, Zou Y: Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis. Journal of translational medicine 2023, 21:192. 22. Vu KN, Ballantyne CM, Hoogeveen RC, Nambi V, Volcik KA, Boerwinkle E, Morrison AC: Causal role of alcohol consumption in an improved lipid profile: the atherosclerosis risk in communities (ARIC) study. PloS one 2016, 11:e0148765. 23. Gordon B, Chen S, Durstine JL: The effects of exercise training on the traditional lipid profile and beyond. Curr Sports Med Rep 2014, 13:253–259. 24. Tillmann T, Vaucher J, Okbay A, Pikhart H, Peasey A, Kubinova R, Pajak A, Tamosiunas A, Malyutina S, Hartwig FP: Education and coronary heart disease: mendelian randomisation study. bmj 2017, 358:j3542. 25. Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, Wiencke JK, Kelsey KT: DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 2012, 13:86. 26. Salas LA, Zhang Z, Koestler DC, Butler RA, Hansen HM, Molinaro AM, Wiencke JK, Kelsey KT, Christensen BC: Enhanced cell deconvolution of peripheral blood using DNA methylation for high-resolution immune profiling. Nature Communications 2022, 13:761. 27. Zheng SC, Breeze CE, Beck S, Dong D, Zhu T, Ma L, Ye W, Zhang G, Teschendorff AE: EpiDISH web server: Epigenetic Dissection of Intra-Sample-Heterogeneity with online GUI. Bioinformatics 2019, 36:1950–1951. 28. Zeng P, Shao Z, Zhou X: Statistical methods for mediation analysis in the era of high-throughput genomics: Current successes and future challenges. Comput Struct Biotechnol J 2021, 19:3209–3224. 29. Dai JY, Stanford JL, LeBlanc M: A multiple-testing procedure for high-dimensional mediation hypotheses. Journal of the American Statistical Association 2022, 117:198–213. 30. Thissen D, Steinberg L, Kuang D: Quick and easy implementation of the Benjamini-Hochberg procedure for controlling the false positive rate in multiple comparisons. Journal of educational and behavioral statistics 2002, 27:77–83. 31. Tingley D, Yamamoto T, Hirose K, Keele L, Imai K: mediation: R Package for Causal Mediation Analysis. Journal of Statistical Software 2014, 59:1–38. 32. Perera C, Zhang H, Zheng Y, Hou L, Qu A, Zheng C, Xie K, Liu L: HIMA2: high-dimensional mediation analysis and its application in epigenome-wide DNA methylation data. BMC bioinformatics 2022, 23:296. 33. Ren X, Kuan PF: methylGSA: a Bioconductor package and Shiny app for DNA methylation data length bias adjustment in gene set testing. Bioinformatics 2019, 35:1958–1959. 34. Kolde R, Laur S, Adler P, Vilo J: Robust rank aggregation for gene list integration and meta-analysis. Bioinformatics 2012, 28:573–580. 35. Gagnon F, Aïssi D, Carrié A, Morange PE, Trégouët DA: Robust validation of methylation levels association at CPT1A locus with lipid plasma levels. J Lipid Res 2014, 55:1189–1191. 36. Irvin MR, Zhi D, Joehanes R, Mendelson M, Aslibekyan S, Claas SA, Thibeault KS, Patel N, Day K, Jones LW, et al: Epigenome-wide association study of fasting blood lipids in the Genetics of Lipid-lowering Drugs and Diet Network study. Circulation 2014, 130:565–572. 37. Maas SC, Mens MM, Kühnel B, van Meurs JB, Uitterlinden AG, Peters A, Prokisch H, Herder C, Grallert H, Kunze S: Smoking-related changes in DNA methylation and gene expression are associated with cardio-metabolic traits. Clinical epigenetics 2020, 12:157. 38. Philibert R, Beach S, Lei M, Brody G: Changes in DNA methylation at the aryl hydrocarbon receptor repressor may be a new biomarker for smoking. Clinical Epigenetics 2013, 5:19. 39. Zhang Y, Schöttker B, Florath I, Stock C, Butterbach K, Holleczek B, Mons U, Brenner H: Smoking-Associated DNA Methylation Biomarkers and Their Predictive Value for All-Cause and Cardiovascular Mortality. Environmental Health Perspectives 2016, 124:67–74. 40. Wen D, Shi J-W, Liu Y, He W, Qu W, Wang C, Xing H, Cao Y, Li J, Zha L: DNA methylation analysis for smoking status prediction in the Chinese population based on the methylation-sensitive single-nucleotide primer extension method. Forensic science international 2022, 339:111412. 41. Philibert R, Moody J, Philibert W, Dogan M, Hoffman E: The Reversion of the Epigenetic Signature of Coronary Heart Disease in Response to Smoking Cessation. Genes 2023, 14:1233. 42. Reynolds LM, Wan M, Ding J, Taylor JR, Lohman K, Su D, Bennett BD, Porter DK, Gimple R, Pittman GS, et al: DNA Methylation of the Aryl Hydrocarbon Receptor Repressor Associations With Cigarette Smoking and Subclinical Atherosclerosis. Circ Cardiovasc Genet 2015, 8:707–716. 43. Jones GT, Williams MJA, Khashram M, Fitzgerald S, Lyons OTA, Griffin CL, Lesche S, Krysa J, Coffey S: A DNA Methylation Marker, cg05575921 (AHRR), Outperforms Self-Reported Smoking Exposure for Its Association With Cardiovascular Disease Prevalence. Nicotine Tob Res 2026, 28:422–428. 44. Saint-André V, Charbit B, Biton A, Rouilly V, Possémé C, Bertrand A, Rotival M, Bergstedt J, Patin E, Albert ML, et al: Smoking changes adaptive immunity with persistent effects. Nature 2024, 626:827–835. 45. Su X, Zhang G, Cheng Y, Wang B: New insights into the emerging effects of inflammatory response on HDL particles structure and function. Molecular Biology Reports 2021, 48:5723–5733. 46. Trakaki A, Marsche G: Current Understanding of the Immunomodulatory Activities of High-Density Lipoproteins. Biomedicines 2021, 9:587. | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/104571 | - |
| dc.description.abstract | 吸菸是心血管疾病(cardiovascular disease, CVD)已知的重要危險因子,並與脂質特徵相關,例如高密度脂蛋白膽固醇(high-density lipoprotein cholesterol, HDL-C)與三酸甘油酯(triglycerides, TG)。DNA 甲基化可能是解釋這些關聯背後的表觀遺傳途徑之一。據此,本研究旨在探討 DNA 甲基化在吸菸與脂質特徵之間關聯中可能扮演的中介角色。
本研究使用臺灣人體生物資料庫中 2,463 名參與者的全基因組 DNA 甲基化資料進行高維度中介分析。首先,使用調整潛在混雜因子的線性回歸模型,評估吸菸狀態與脂質特徵之間的關聯。接著,針對具有顯著關聯的吸菸-脂質特徵組合,應用高維度中介檢定(high-dimensional mediation testing, HDMT)以辨識可能作為中介因子的 CpG 位點(FDR < 0.05)。為估計整體中介比例,本研究針對辨識出的 CpG 位點進行主成分分析,並透過基於主成分建立的中介模型估計潛在中介因子的中介比例。為進一步篩選出具獨立中介效應的位點,本研究使用 HIMA2建立多中介因子模型以同時考慮多個中介位點。 以目前吸菸作為暴露變項時,在 846,232個 CpG 位點中,分別有 109個與 65個 CpG 位點被辨識為吸菸-HDL-C 與吸菸-log(TG) 關聯中的顯著中介因子。DNA 甲基化估計分別可解釋吸菸與 HDL-C 及 log(TG)關聯中約 65% 與 7% 的中介比例。多重中介因子模型進一步辨識出14個與 HDL-C 相關以及1個與TG相關的獨立中介 CpG 位點。 本研究結果為DNA甲基化參與吸菸與脂質特徵之間的關聯的可能性提供了統計支持。然而,受到橫斷面研究之故有侷限,仍待後續的縱向研究與功能性研究,以闡明其潛在的生物學脈絡。 | zh_TW |
| dc.description.abstract | Cigarette smoking is a well-established risk factor for cardiovascular disease (CVD) and is associated with lipid traits such as high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG). DNA methylation may represent an epigenetic mechanism underlying these associations. This study aimed to explore the potential mediating role of DNA methylation in the association between smoking and lipid traits.
High-dimensional mediation analysis was performed using genome-wide DNA methylation data (Illumina EPIC Array) from 2,463 participants in the Taiwan Biobank (TWB). Linear regression models adjusted for potential confounders were used to assess the associations between smoking status and lipid traits. High-dimensional mediation testing (HDMT) was then applied to identify CpG sites that potentially act as mediators (FDR < 0.05) of the significantly associated smoking–lipid pairs. To estimate the overall mediation proportion, principal component analysis (PCA) was performed on the identified CpG sites, and the mediation proportion explained by the top principal components was estimated. In addition, HIMA2 was applied to identify independent mediating CpG sites. Using current smoking as the exposure, among 846,232 CpG sites, 109 and 65 CpG sites were identified by HDMT as potential mediators of the smoking–HDL-C and smoking–log(TG) associations, respectively. The net PCA-based mediation estimates across significant principal components were approximately 65% for HDL-C and 7% for log(TG). For log(TG), six principal components showed significant indirect effects in opposing directions, resulting in substantial cancellation in the net estimate. HIMA2 identified 14 joint-model mediation signals for HDL-C and identified cg00574958 in CPT1A for log(TG). These findings provide statistical evidence supporting a potential role of DNA methylation in the association between smoking and lipid traits. Further longitudinal and functional studies are needed to clarify the underlying biological mechanisms. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2026-08-28T16:26:24Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2026-08-28T16:26:24Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 誌謝 ii
中文摘要 iii Abstract iv 目次 vii 圖次 vii 表次 viii Introduction 1 Materials and Methods 3 The Taiwan Biobank data 3 Quality Control for methylation data 3 Smoking factors and lipid traits 5 Covariates 6 Association analysis 6 Mediation analysis 6 Functional enrichment analysis 10 Results 11 Sample characteristics 11 Associations between smoking and lipid traits 12 Mediation analysis 12 Functional enrichment analysis 14 Discussion 15 Conclusion 21 Tables 22 Figures 24 References 33 | - |
| dc.language.iso | en | - |
| dc.subject | 吸菸 | - |
| dc.subject | DNA 甲基化 | - |
| dc.subject | 脂質特徵 | - |
| dc.subject | 表觀遺傳學 | - |
| dc.subject | 高維度中介分析 | - |
| dc.subject | 臺灣人體生物資料庫 | - |
| dc.subject | smoking | - |
| dc.subject | DNA methylation | - |
| dc.subject | lipid traits | - |
| dc.subject | epigenetics | - |
| dc.subject | High-dimensional mediation analysis | - |
| dc.subject | Taiwan Biobank | - |
| dc.title | DNA甲基化在吸菸與血脂性狀之間的中介作用 | zh_TW |
| dc.title | DNA methylation may mediate the association between smoking and lipid traits | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 114-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 馮嬿臻;陳弘昕 | zh_TW |
| dc.contributor.oralexamcommittee | Yen-Chen Feng;Hung-Hsin Chen | en |
| dc.subject.keyword | 吸菸; DNA 甲基化; 脂質特徵; 表觀遺傳學; 高維度中介分析; 臺灣人體生物資料庫 | zh_TW |
| dc.subject.keyword | smoking; DNA methylation; lipid traits; epigenetics; High-dimensional mediation analysis; Taiwan Biobank | en |
| dc.relation.page | 37 | - |
| dc.identifier.doi | 10.6342/NTU202604328 | - |
| dc.rights.note | 同意授權(全球公開) | - |
| dc.date.accepted | 2026-08-17 | - |
| dc.contributor.author-college | 公共衛生學院 | - |
| dc.contributor.author-dept | 健康數據拓析統計研究所 | - |
| dc.date.embargo-lift | 2026-08-29 | - |
| 顯示於系所單位: | 健康數據拓析統計研究所 | |
文件中的檔案:
| 檔案 | 描述 | 大小 | 格式 | |
|---|---|---|---|---|
| ntu-114-2.pdf | 1.17 MB | Adobe PDF | 檢視/開啟 | |
| ntu-114-2.pdf | 1.17 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
